Loading...
What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study
McWilliams, L. Ruane, H. Ulph, F. Woof, V. G. Harrison, F. Evans, D Gareth R French, David P
McWilliams, L.
Ruane, H.
Ulph, F.
Woof, V. G.
Harrison, F.
Evans, D Gareth R
French, David P
Citations
Altmetric:
Abstract
Background: Risk-stratified screening is being considered for national breast screening programmes. It is unclear how women experience risk-stratified screening and receipt of breast cancer risk information in real time. This study aimed to explore the psychological impact of undergoing risk-stratified screening within England's NHS Breast Screening Programme.
Methods: Individual telephone interviews were conducted with 40 women who participated in the BC-Predict study and received a letter indicating their estimated breast cancer risk as one of four risk categories: low (<2% 10-year risk), average (2-4.99%), above average (moderate; 5-7.99%) or high (≥8%). Audio-recorded interview transcriptions were analysed using reflexive thematic analysis.
Results: Two themes were produced: 'From risk expectations to what's my future health story?' highlights that women overall valued the opportunity to receive risk estimates; however, when these were discordant with perceived risk, this causes temporary distress or rejection of the information. 'Being a good (woman) citizen' where women felt positive contributing to society but may feel judged if they then cannot exert agency over the management of their risk or access follow-up support CONCLUSIONS: Risk-stratified breast screening was generally accepted without causing long-lasting distress; however, issues related to risk communication and access to care pathways need to be considered for implementation.
Description
Date
2023
Publisher
Collections
Files
Keywords
Type
Article
Citation
McWilliams L, Ruane H, Ulph F, Woof VG, Harrison F, Evans DG, et al. What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study. British journal of cancer. 2023 May 24:1-10. PubMed PMID: 37225893. Pubmed Central PMCID: PMC10206350 AstraZeneca and Everything Genetic. Epub 2023/05/25. eng.